期刊
MOLECULAR ONCOLOGY
卷 11, 期 1, 页码 62-78出版社
WILEY
DOI: 10.1016/j.molonc.2016.09.009
关键词
breast cancer; cancer; dormancy; latency; metastasis
类别
资金
- La Caixa PhD fellowship
- Institucio Catalana de Recerca i Estudis Avancats
- BBVA Foundation
- Generalitat de Catalunya [SGR 535]
- Spanish Ministerio de Economia y Competitividad (MINECO)
- FEDER [SAF2013-46196-R, SAF2016-76008-R]
Metastasis is the primary cause of death in cancer patients and current treatments fail to provide durable responses. Efforts to treat metastatic disease are hindered by the fact that metastatic cells often remain dormant for prolonged intervals of years, or even decades. Tumor dormancy reflects the capability of disseminated tumor cells (DTCs), or micrometastases, to evade treatment and remain at low numbers after primary tumor resection. Unfortunately, dormant cells will eventually produce overt metastasis. Innovations are needed to understand metastatic dormancy and improve cancer detection and treatment. Currently, few models exist that faithfully recapitulate metastatic dormancy and metastasis to clinically relevant tissues, such as the bone. Herein, we discuss recent advances describing genetic cell-autonomous and systemic or local changes in the microenvironment that have been shown to endow DTCs with properties to survive and eventually colonize distant organs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据